Small print.
Wide open.

From  May  2026  to  June  2026,  we  sold  an  aggregate  of  (i)  77,637,878  shares  of  our  Series  H-1  redeemable 
convertible  preferred  stock  to  305  accredited  investors  at  a  purchase  price  of  $589.0095  per  share,  for  an 
aggregate purchase price of approximately $45.7 billion, and (ii) 33,110,291 shares of our Series H-2 non-voting 
redeemable convertible preferred stock to 11 accredited investors at a purchase price of $589.0095 per share, 
for an aggregate purchase price of approximately $19.5 billion. 

Convertible Note Issuances

From November 2023 through the filing date of this registration statement, we issued convertible promissory 
notes in an aggregate principal amount of $10.2 billion to two accredited investors. 

Option, RSU, and RSA Issuances 

From  November  2023  through  the  filing  date  of  this  registration  statement,  we  granted  to  our  directors, 
officers, employees, consultants, and other service providers options to purchase an aggregate of 2,066,876,470 
shares  of  our  Class  A  common  stock  under  our  equity  compensation  plans  at  exercise  prices  ranging  from 
approximately $0.6420 to $57.5360 per share. 

From November 2023 through the filing date of this registration statement, we issued to our directors, officers, 
employees, consultants, and other service providers an aggregate of 409,116,603 shares of our Class A common 
stock  upon  the  exercise  of  options  under  our  equity  compensation  plans  at  exercise  prices  ranging  from 
approximately $0.0859 to $24.5360 per share, for a weighted-average exercise price of $1.2043. 

From  November  2023  through  the  filing  date  of  this  registration  statement,  we  granted  to  our  directors, 
officers, employees, consultants, and other service providers an aggregate of 1,171,364,280 RSUs to be settled in 
shares of our Class A common stock under our equity compensation plans. 

From  November  2023  through  the  filing  date  of  this  registration  statement,  we  granted  to  our  directors, 
officers, employees, consultants, and other service providers RSAs covering an aggregate of 214,960 shares of 
our Class A common stock under our equity compensation plans. 

Securities Issued in Connection with Acquisitions 

From  November  2023  through  the  filing  date  of  this  registration  statement,  we  issued  an  aggregate  of 
37,215,830 shares of our Class A common stock, 848,882 shares of our Class N common stock, and options to 
purchase 376,320 shares of our Class A common stock in connection with our acquisitions of certain companies 
or  their  assets  and  as  consideration  to  individuals  and  entities  who  were  former  service  providers  or 
stockholders of such companies.

None of the foregoing transactions involved any underwriters, underwriting discounts or commissions, or any 
public offering. We believe the offers, sales, and issuances of the above securities were exempt from registration 
under the Securities Act (or Regulation D or Regulation S promulgated thereunder) by virtue of Section 4(a)(2) 
of the Securities Act because the issuance of securities to the recipients did not involve a public offering, or in 
reliance  on  Rule  701  because  the  transactions  were  pursuant  to  compensatory  benefit  plans  or  contracts 
relating  to  compensation  as  provided  under  such  rule.  The  recipients  of  the  securities  in  each  of  these 
transactions represented their intentions to acquire the securities for investment only and not with a view to or 
for  sale  in  connection  with  any  distribution  thereof,  and  appropriate  legends  were  placed  upon  the  stock 
certificates issued in these transactions. All recipients had adequate access, through their relationships with us, 
to information about us. The sales of these securities were made without any general solicitation or advertising. 

II-4